Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,148 | 333 | 99.0% |
| Education | $99.99 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $4,515 | 107 | $0 (2024) |
| BIOTRONIK INC. | $1,652 | 40 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,036 | 52 | $0 (2024) |
| Abbott Laboratories | $573.32 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $337.49 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $252.09 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $243.85 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $182.68 | 11 | $0 (2024) |
| Philips Electronics North America Corporation | $153.05 | 3 | $0 (2023) |
| Cook Incorporated | $139.33 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,035 | 53 | Boston Scientific Corporation ($224.94) |
| 2023 | $1,327 | 49 | Boston Scientific Corporation ($411.56) |
| 2022 | $1,286 | 28 | Boston Scientific Corporation ($969.66) |
| 2021 | $921.90 | 25 | BOSTON SCIENTIFIC CORPORATION ($627.65) |
| 2020 | $875.49 | 27 | Boston Scientific Corporation ($756.38) |
| 2019 | $1,176 | 32 | Boston Scientific Corporation ($886.43) |
| 2018 | $1,435 | 44 | BIOTRONIK INC. ($514.24) |
| 2017 | $2,193 | 76 | BIOTRONIK INC. ($993.77) |
All Payment Transactions
334 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Structural Heart | ||||||
| 12/23/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $19.58 | General |
| Category: Cardiology | ||||||
| 12/14/2024 | Boston Scientific Corporation | ZOOM Wireless Transmitter (Device) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: ZOOM_CRM | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.27 | General |
| Category: Cardiovascular | ||||||
| 12/09/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/16/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/03/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $30.62 | General |
| Category: Medical Device | ||||||
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.75 | General |
| Category: Cardiovascular | ||||||
| 09/27/2024 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: LUX-Dx_CRM | ||||||
| 09/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: DIABETES | ||||||
| 09/14/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/12/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $17.42 | General |
| Category: Endovascular | ||||||
| 09/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Not Applicable | ||||||
| 09/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.42 | General |
| Category: Cardiovascular | ||||||
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: DIABETES | ||||||
| 08/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/12/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.14 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/08/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 08/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Structural Heart | ||||||
| 07/13/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.54 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/15/2024 | Recor Medical Inc | PARADISE RENAL DENERVATION SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $24.05 | General |
| Category: Endovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 2,530 | 3,272 | $375,168 | $112,768 |
| 2022 | 30 | 5,978 | 9,433 | $520,819 | $244,004 |
| 2021 | 30 | 7,026 | 11,522 | $584,142 | $289,362 |
| 2020 | 28 | 5,761 | 9,131 | $475,423 | $235,278 |
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 256 | 356 | $77,824 | $23,189 | 29.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 599 | 857 | $29,112 | $8,606 | 29.6% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 161 | 208 | $22,055 | $7,872 | 35.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 69 | 71 | $23,425 | $6,945 | 29.6% |
| 33208 | Insertion of pacemaker and upper and lower heart chamber electrode | Facility | 2023 | 18 | 19 | $24,849 | $6,838 | 27.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 80 | 80 | $21,698 | $6,062 | 27.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 210 | 270 | $20,015 | $5,262 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 47 | 47 | $18,995 | $5,236 | 27.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 264 | 326 | $16,857 | $4,325 | 25.7% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 64 | 102 | $9,675 | $3,805 | 39.3% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 57 | 74 | $6,251 | $3,680 | 58.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 36 | $11,036 | $3,168 | 28.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 50 | $8,677 | $2,912 | 33.6% |
| 96156 | Assessment of health behavior | Office | 2023 | 12 | 42 | $10,022 | $2,824 | 28.2% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 30 | 33 | $5,916 | $2,711 | 45.8% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 43 | 48 | $4,734 | $2,597 | 54.9% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 123 | 123 | $7,772 | $2,380 | 30.6% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 71 | 96 | $8,813 | $2,300 | 26.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 30 | 38 | $7,987 | $1,824 | 22.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 28 | 29 | $7,153 | $1,798 | 25.1% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 23 | 41 | $2,347 | $1,448 | 61.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $3,950 | $988.27 | 25.0% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 26 | 49 | $3,183 | $903.99 | 28.4% |
| 93281 | Programming of multiple lead pacemaker system | Office | 2023 | 12 | 13 | $1,302 | $802.49 | 61.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 21 | $2,821 | $796.57 | 28.2% |
About Dr. Kenneth Judson, DO
Dr. Kenneth Judson, DO is a Cardiovascular Disease healthcare provider based in Morgantown, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770525891.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Judson, DO has received a total of $10,248 in payments from pharmaceutical and medical device companies, with $1,035 received in 2024. These payments were reported across 334 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($10,148).
As a Medicare-enrolled provider, Judson has provided services to 21,295 Medicare beneficiaries, totaling 33,358 services with total Medicare billing of $881,411. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Clinical Cardiac Electrophysiology, Clinical Cardiac Electrophysiology
- Location Morgantown, WV
- Active Since 06/12/2006
- Last Updated 12/22/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1770525891
Products in Payments
- EMBLEM (Device) $1,800
- LifeVest (Device) $1,036
- LUX-Dx Insertable Cardiac Monitor (Device) $518.64
- EMBLEM MRI S-ICD (Device) $472.37
- ELIQUIS (Drug) $368.45
- COOK MEDICAL LEAD MANAGEMENT - LEAD EXTRACTION (Device) $268.24
- SQ-RX PULSE GENERATOR (Device) $231.87
- ENTRESTO (Drug) $197.78
- BRILINTA (Drug) $186.51
- XARELTO (Drug) $182.68
- (5044) MCOT (Device) $182.09
- LUX DX (Device) $170.84
- CRT-Ds (Device) $163.41
- General - Therapies (Device) $137.83
- KENGREAL (Drug) $120.22
- Fortify Assura, Ellipse ICD (Device) $107.97
- JARDIANCE (Drug) $107.79
- EMBLEM S-ICD (Device) $100.34
- LATITUDE (Device) $95.68
- GENERAL THERAPIES (Device) $94.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Morgantown
Dr. Wissam Gharib, M. D, M. D
Cardiovascular Disease — Payments: $210,394
Dr. Marco Caccamo, Do, DO
Cardiovascular Disease — Payments: $83,056
Dr. Salam Sbaity, M.d, M.D
Cardiovascular Disease — Payments: $51,550
Dr. Anthony Morise, M. D, M. D
Cardiovascular Disease — Payments: $33,788
Dr. Madhavi Kadiyala, Md, MD
Cardiovascular Disease — Payments: $24,320
David Campsey, Md, MD
Cardiovascular Disease — Payments: $22,060